Dr Brian Davies ND BSc  

P: 778-340-1114 - F: 778-340-7702 - Unit 102 – 88 Lonsdale Avenue North Vancouver, BC V7M 2E6

New Study on the Flu Vaccine

Posted on 1st March, by Westcoast Integrative Health in From the blog, Immunology - Immune and Cancer. Comments Off

New Study on the Flu Vaccine

Here is the latest and greatest on the flu vaccination!

According to this meta-analysis that included over 80000 people between the ages of 15 and 65 years of age there was a whopping 1% absolute reduction in the incidence of flu with the use of the vaccine.

This article, is by no means, meant to sway people from a medical intervention that they believe in! Vaccines are a personal decision and a very controversial topic, but I think it is important for people to know the benefits that should be expected from this intervention and the risks associated with the use of vaccines, mainly being from a small, yet significant among of the adjuvant thimerosil (Ethylmercury).

It should also be noted that in populations more at risk, although not reviewed in the follow study, the flu vaccination is known to have an even lower protective benefit. This includes children, pregnant women and people over the age of 65 years of age.

Although, in no way is this article suggesting that there is no benefit to the flu vaccination (1%), but it is my solemn hope that people will consider other means of protecting themselves against the flu and other diseases, regardless of vaccination or not, using simple hand washing and common sense when they are sick, by staying at home or covering their mouth when they cough. It is also my hope, in the future, that we can come up with better solutions to maintain the health of our population against the flu!

BACKGROUND: The consequences of influenza in adults are mainly time off work. Vaccination of pregnant women is recommended internationally. This is an update of a review published in 2014. Future updates of this review will be made only when new trials or vaccines become available. Observational data included in previous versions of the review have been retained for historical reasons but have not been updated due to their lack of influence on the review conclusions.

OBJECTIVES: To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in healthy adults, including pregnant women.

SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 12), MEDLINE (January 1966 to 31 December 2016), Embase (1990 to 31 December 2016), the WHO International Clinical Trials Registry Platform (ICTRP; 1 July 2017), and ClinicalTrials.gov (1 July 2017), as well as checking the bibliographies of retrieved articles.

SELECTION CRITERIA: Randomised controlled trials (RCTs) or quasi-RCTs comparing influenza vaccines with placebo or no intervention in naturally occurring influenza in healthy individuals aged 16 to 65 years. Previous versions of this review included observational comparative studies assessing serious and rare harms cohort and case-control studies. Due to the uncertain quality of observational (i.e. non-randomised) studies and their lack of influence on the review conclusions, we decided to update only randomised evidence. The searches for observational comparative studies are no longer updated.

DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. We rated certainty of evidence for key outcomes (influenza, influenza-like illness (ILI), hospitalisation, and adverse effects) using GRADE.

MAIN RESULTS: We included 52 clinical trials of over 80,000 people assessing the safety and effectiveness of influenza vaccines. We have presented findings from 25 studies comparing inactivated parenteral influenza vaccine against placebo or do-nothing control groups as the most relevant to decision-making. The studies were conducted over single influenza seasons in North America, South America, and Europe between 1969 and 2009. We did not consider studies at high risk of bias to influence the results of our outcomes except for hospitalisation.Inactivated influenza vaccines probably reduce influenza in healthy adults from 2.3% without vaccination to 0.9% (risk ratio (RR) 0.41, 95% confidence interval (CI) 0.36 to 0.47; 71,221 participants; moderate-certainty evidence), and they probably reduce ILI from 21.5% to 18.1% (RR 0.84, 95% CI 0.75 to 0.95; 25,795 participants; moderate-certainty evidence; 71 healthy adults need to be vaccinated to prevent one of them experiencing influenza, and 29 healthy adults need to be vaccinated to prevent one of them experiencing an ILI). The difference between the two number needed to vaccinate (NNV) values depends on the different incidence of ILI and confirmed influenza among the study populations. Vaccination may lead to a small reduction in the risk of hospitalisation in healthy adults, from 14.7% to 14.1%, but the CI is wide and does not rule out a large benefit (RR 0.96, 95% CI 0.85 to 1.08; 11,924 participants; low-certainty evidence). Vaccines may lead to little or no small reduction in days off work (-0.04 days, 95% CI -0.14 days to 0.06; low-certainty evidence). Inactivated vaccines cause an increase in fever from 1.5% to 2.3%.We identified one RCT and one controlled clinical trial assessing the effects of vaccination in pregnant women. The efficacy of inactivated vaccine containing pH1N1 against influenza was 50% (95% CI 14% to 71%) in mothers (NNV 55), and 49% (95% CI 12% to 70%) in infants up to 24 weeks (NNV 56). No data were available on efficacy against seasonal influenza during pregnancy. Evidence from observational studies showed effectiveness of influenza vaccines against ILI in pregnant women to be 24% (95% CI 11% to 36%, NNV 94), and against influenza in newborns from vaccinated women to be 41% (95% CI 6% to 63%, NNV 27).Live aerosol vaccines have an overall effectiveness corresponding to an NNV of 46. The performance of one- or two-dose whole-virion 1968 to 1969 pandemic vaccines was higher (NNV 16) against ILI and (NNV 35) against influenza. There was limited impact on hospitalisations in the 1968 to 1969 pandemic (NNV 94). The administration of both seasonal and 2009 pandemic vaccines during pregnancy had no significant effect on abortion or neonatal death, but this was based on observational data sets.

AUTHORS’ CONCLUSIONS: Healthy adults who receive inactivated parenteral influenza vaccine rather than no vaccine probably experience less influenza, from just over 2% to just under 1% (moderate-certainty evidence). They also probably experience less ILI following vaccination, but the degree of benefit when expressed in absolute terms varied across different settings. Variation in protection against ILI may be due in part to inconsistent symptom classification. Certainty of evidence for the small reductions in hospitalisations and time off work is low. Protection against influenza and ILI in mothers and newborns was smaller than the effects seen in other populations considered in this review.Vaccines increase the risk of a number of adverse events, including a small increase in fever, but rates of nausea and vomiting are uncertain. The protective effect of vaccination in pregnant women and newborns is also very modest. We did not find any evidence of an association between influenza vaccination and serious adverse events in the comparative studies considered in this review. Fifteen included RCTs were industry funded (29%).


Comments are closed.

From The Blog

Keep up-to-date on health tips and research with Westcoast Integrative Health's blog feed.Search our site for articles on all different types of health concerns! 

Westcoast Integrative Health is North Vancouver's premium Naturopathic, Orthomolecular and Functional Medicine health facility.

Killing Your Cold and Sesonal Allergies

This year has been a particularity brutal cold and flu season with currently no end in sight, but allergy season is also right around...

New Study on the Flu Vaccine

Here is the latest and greatest on the flu vaccination!

According to this meta-analysis that included over 80000 people between the ages of 15 and...

Autoimmune Disease – Functional Medicine

The current conventional medical model for the treatment of autoimmunity is focused on immune suppression or the use of biological agents like Humira™. Humira...